Patent · US Active

Protein capable of inhibiting anthrax toxin activity

US8367603B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 19, 2010
Grant dateFeb 5, 2013
Priority date
Expiry dateJul 19, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/415
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention particularly relates to inhibition of the cleavage of protective antigen (PA) of Bacillus anthracis, which subsequently leads to inhibition of activity of anthrax toxin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.